Business

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

Financial Post · September 11, 2026 at 8:32 a.m.

NEW YORK, Sept.

11, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio @ IBN ( InvestorBrandNetwork ) , a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

More from Financial Post

Phoenix Tailings Advances Rare Earth Separation Engineering

Trident Provides Updated Information Regarding Its Marketing Engagement with Freedom Financial Research, LLC

This TSX stock could see nearly 32% upside after a huge India deal, analyst says

Brian Kesseler Named CEO of TekniPlex

More in Business

Phoenix Tailings Advances Rare Earth Separation Engineering

Trident Provides Updated Information Regarding Its Marketing Engagement with Freedom Financial Research, LLC

This TSX stock could see nearly 32% upside after a huge India deal, analyst says

Brian Kesseler Named CEO of TekniPlex

San Lorenzo Announces Upsize of Private Placement to Up to $80 Million

News of the day: Risky Nigerian mining, Super El Niño, banks in U.S. crosshairs, immigration boost, inheritance law and more